Form 8-K - Current report:
SEC Accession No. 0001104659-24-103959
Filing Date
2024-09-30
Accepted
2024-09-30 08:00:32
Documents
21
Period of Report
2024-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425134d1_8k.htm   iXBRL 8-K 39398
2 EXHIBIT 4.1 tm2425134d1_ex4-1.htm EX-4.1 101634
3 EXHIBIT 4.2 tm2425134d1_ex4-2.htm EX-4.2 98886
4 EXHIBIT 5.1 tm2425134d1_ex5-1.htm EX-5.1 15485
5 EXHIBIT 10.1 tm2425134d1_ex10-1.htm EX-10.1 176349
6 EXHIBIT 99.1 tm2425134d1_ex99-1.htm EX-99.1 11248
10 GRAPHIC tm2425134d1_ex5-1img001.jpg GRAPHIC 23676
11 GRAPHIC tm2425134d1_ex5-1img002.jpg GRAPHIC 13996
12 GRAPHIC tm2425134d1_ex5-1img003.jpg GRAPHIC 3789
  Complete submission text file 0001104659-24-103959.txt   787476

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eyen-20240926.xsd EX-101.SCH 3015
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20240926_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20240926_pre.xml EX-101.PRE 22359
23 EXTRACTED XBRL INSTANCE DOCUMENT tm2425134d1_8k_htm.xml XML 3666
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 241336710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)